Health Care - As enacted, adds nonopioid medicinal drugs or drug products, occupational therapy, and interventional procedures or treatments to the alternative treatments that must be disclosed and explained by a healthcare practitioner to a patient or the patient's legal representative as a prerequisite to obtaining informed consent to treatment with an opioid. - Amends TCA Section 63-1-164.
6 recorded connections shown. Select a record, office or person to follow its source references.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Health Care - As enacted, adds nonopioid medicinal drugs or drug products, occupational therapy, and interventional procedures or treatments to the alternative treatments that must be disclosed and explained by a healthcare practitioner to a patient or the patient's legal representative as a prerequisite to obtaining informed consent to treatment with an opioid. - Amends TCA Section 63-1-164.
Measures · Date not recorded
The source record
The source did not record a date for this entry.
- Jurisdiction code
- TN
- Identifier
- SB 1912
- Number
- 1912
- Title
- Health Care - As enacted, adds nonopioid medicinal drugs or drug products, occupational therapy, and interventional procedures or treatments to the alternative treatments that must be disclosed and explained by a healthcare practitioner to a patient or the patient's legal representative as a prerequisite to obtaining informed consent to treatment with an opioid. - Amends TCA Section 63-1-164.
- Is law candidate
- true
- Current stage
- enacted
- Latest action at
- 2020-03-26T00:00:00+00:00
- Official url
- https://openstates.org/
- Source updated at
- 2020-08-23T12:40:55.982029+00:00
- First seen at
- 2026-08-19T17:11:43.543975+00:00
- Last seen at
- 2026-10-05T09:01:12.958048+00:00
- Metadata
- {}
- Government level
- state
Every link on this map
The same connections as a table, with the reason each one is here.
| Measures | What this connects to | Health Care - As enacted, adds nonopioid medicinal drugs or drug products, occupational therapy, and interventional procedures or treatments to the alternative treatments that must be disclosed and explained by a healthcare practitioner to a patient or the patient's legal representative as a prerequisite to obtaining informed consent to treatment with an opioid. - Amends TCA Section 63-1-164. has a recorded connection to Measures. | None |
| SB 1912: Health Care - As enacted, adds nonopioid medicinal drugs or drug products, occupational therapy, and interventional procedures or treatments to the alternative treatments that must be disclosed and explained by a healthcare practitioner to a patient or the patient's legal representative as a prerequisite to obtaining informed consent to treatment with an opioid. - Amends TCA Section 63-1-164 | What this connects to | Health Care - As enacted, adds nonopioid medicinal drugs or drug products, occupational therapy, and interventional procedures or treatments to the alternative treatments that must be disclosed and explained by a healthcare practitioner to a patient or the patient's legal representative as a prerequisite to obtaining informed consent to treatment with an opioid. - Amends TCA Section 63-1-164. has a recorded connection to SB 1912. | None |
| Tennessee 111 | What this connects to | Health Care - As enacted, adds nonopioid medicinal drugs or drug products, occupational therapy, and interventional procedures or treatments to the alternative treatments that must be disclosed and explained by a healthcare practitioner to a patient or the patient's legal representative as a prerequisite to obtaining informed consent to treatment with an opioid. - Amends TCA Section 63-1-164. has a recorded connection to Tennessee 111. | None |
| Tennessee | What this connects to | Health Care - As enacted, adds nonopioid medicinal drugs or drug products, occupational therapy, and interventional procedures or treatments to the alternative treatments that must be disclosed and explained by a healthcare practitioner to a patient or the patient's legal representative as a prerequisite to obtaining informed consent to treatment with an opioid. - Amends TCA Section 63-1-164. has a recorded connection to Tennessee. | None |
| ocd-bill/ab88047c-8af8-4ba9-ac65-a15dbdefb0f4 | What this connects to | Health Care - As enacted, adds nonopioid medicinal drugs or drug products, occupational therapy, and interventional procedures or treatments to the alternative treatments that must be disclosed and explained by a healthcare practitioner to a patient or the patient's legal representative as a prerequisite to obtaining informed consent to treatment with an opioid. - Amends TCA Section 63-1-164. has a recorded connection to ocd-bill/ab88047c-8af8-4ba9-ac65-a15dbdefb0f4. | None |
| Tennessee | What this connects to | Health Care - As enacted, adds nonopioid medicinal drugs or drug products, occupational therapy, and interventional procedures or treatments to the alternative treatments that must be disclosed and explained by a healthcare practitioner to a patient or the patient's legal representative as a prerequisite to obtaining informed consent to treatment with an opioid. - Amends TCA Section 63-1-164. has a recorded connection to Tennessee. | None |